RSNA pavilion to emphasize the integration of the people and products of R2
Technology and Suros Surgical Systems into the Hologic vision of the future
BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/ -- Hologic, Inc.
(Nasdaq: HOLX), a leading provider of state-of-the-art diagnostic and
digital imaging systems for women's imaging and skeletal health, will again
be one of the largest exhibitors at the 92nd Scientific Assembly and Annual
Meeting of the Radiological Society of North America (RSNA). With a
pavilion one third bigger than last year, the Hologic exhibit will cover
over 13,000 sq. ft. of the Chicago McCormick Place North Hall exhibit
space.
Hologic's theme for the show is "Better Together," to emphasize how the
Company has integrated the people and resources of R2 Technology and Suros
Surgical Systems into Hologic's vision of making a difference in the lives
of women everywhere.
"Hologic is continuing to lead the way in developing and bringing to
women's imaging and skeletal health products that help patients enjoy
longer and healthier lives," said Jack Cumming, Hologic Chairman and CEO.
"We believe our ability to utilize technology to understand disease
earlier, improve clinical workflow and decrease costs will have a
signifuicant impact on the future of healthcare."
Women's Imaging
The Most Popular Digital Mammography Solutions on the Market Today
As better detection through better imaging, digital connectivity and
interoperability continue to drive women's imaging, the Hologic pavillion
will feature the newly enhanced Selenia(TM), one of the most popular
digital mammography platform on the market today, and SecurViewDX(TM)
diagnostic workstations -- workstations that put the tools and workflow
designed by and for the radiologist right at the users fingertips.
SecurView can display digital mammograms from any vendor, locate
regions of interest using sophisticated CAD tools and view current and
prior mammograms alongside breast images from MRI, PET and ultrasound with
seamless file sharing. SecurView diagnostic workstations automatically
recognize the breast imaging procedure based on procedure name or image
content. Users now have a limitless number of image hanging protocols based
on individual preferences that are customized to your workflow and reading
preferences. Images can be manipulated and annotations added intuitively,
plus synchronization across multiple mammography applications to optimize
the way they really work.
Visitors to the Hologic pavilion will have the chance to see for
themselves, on fifteen SecurView multimodality workstations, how Selenia
and SecurView provides the foundation for Hologic's digital mammography
suite. Particular emphasis will be put on the advanced hanging protocols
and ability to view breast tomosynthesis images.
Selenia plus SecurView gives you more useful diagnostic images, better
tools to interpret them, and faster, more flexible access to them.
Hologic RSNA Digital Mammography Self-Assessment Workshop
A major hit at RSNA'05, the Hologic co-sponsored Digital Mammography
Training and Self-Assessment Workshop is back again with more workstations
and expanded teaching modules. Workshop participants have the unique
opportunity for hands-on experience reading and manipulating screening
digital mammography cases on high-end flat panel workstations. To register
or obtain more information, logon to the http://www.RSNA.org web site.
The First and Latest in Mammography Computer Aided Detection
Following Hologic's acquisition of R2 Technology, R2 mammography
applications software tools including Citra(TM) are being fully integrated
into the Hologic line of multi-modality breast imaging workstations.
For analog facilities, Hologic will demonstrate how DigitalNow(TM), a
product developed for the thousands of mammography facilities that see
digital in their future. DigitalNow allows users to build a library of
digitized prior mammograms and helps facilitate a seamless transition to
softcopy review when the facility transitions to digital. DigitalNow
improves the digital reading environment and workflow by eliminating the
need for light boxes next to high-resolution monitors. This state of the
art product features universal compatibility with all DICOM workstations
and flexible electronic patient data system integration.
R2 technology was the first CAD system, approved by the FDA for use
with film-based mammography in 1998 and for digital mammography in 2001. To
date, more than 2,600 R2 mammography CAD systems have been sold worldwide.
Hologic estimates that more than ten million women will have their
mammograms interpreted with the aid of R2's CAD technology within the next
12 months.
Advanced Biopsy Solutions for the Breast Biopsy Suite
Designed with user input and practical considerations in mind, Hologic
will showcase upright and prone stereotactic breast biopsy solutions
including the MultiCare Platinum(TM), the most popular prone biopsy table
on the market today.
With the acquisition of Suros, ATEC(R) Automated Tissue Excision and
Collection systems have been optimized for use with the MultiCare Platinum
prone and StereoLoc II(TM) upright biopsy systems. ATEC breast biopsy and
excision systems offer multiple clinical benefits including diverse needle
options to accommodate a wide variety of patient presentations, continuous
pain management, and a fully closed system with tissue acquisition every
4.5 seconds, and ATEC is carefully engineered to reduce patent recovery
time, emotional stress, and expense.
Suros launched the first-ever MRI compatible vacuum assisted biopsy
device in 2003. To date, nearly 200,000 ATEC breast biopsies have been
successfully completed -- 15,000 using MRI guidance. As breast MRI
continues to gain prominence as a mainstream imaging technique for women
with dense breast tissue and at high-risk for breast cancer, Suros saw a
need for a dedicated breast MRI system and developed the ATEC Emerald.
The ATEC Emerald(TM) is designed specifically for clinicians requiring
a more mobile solution to perform MRI-guided breast biopsy and for
facilities with dedicated breast MRI programs. The ATEC Emerald is
MRI-specific and allows the ability to perform a 30-minute MRI-guided
breast biopsy on biopsy patients with multiple lesions in a single
gadolinium injection session. The system can be used with the grid and
pillar-and-post targeting methods, and is compatible with magnet and coil
manufacturers used for breast biopsy.
The ATEC Sapphire(TM) is the first-ever all in one breast biopsy system
that provides radiologists and surgeons the ability to biopsy in any of the
three primary diagnostic imaging modalities of stereotactic x-ray,
ultrasound and MRI using a single biopsy unit.
Skeletal Health
For many years Hologic has set the gold standard in osteoporosis
assessment. In 2006 Hologic expanded its solutions to address the continuum
of skeletal health care, from prevention to intervention. Our goal -- to be
the strong foundation that clinicians rely on in their fight for better
skeletal health for everyone.
New Features Offered on Discovery Bone Densitometer Systems
Discovery(TM) bone densitometers quickly and precisely measures the two
primary diagnostic indicators of osteoporosis -- bone mineral density and
vertebral fractures. At RSNA'06, Hologic will demonstrate how the low dose
Discovery is even better with new functionality including Hip Structure
Analysis(TM) and the use of abdominal aortic calcifications (AACs), as seen
in Discovery IVA scans. AAC is seen as an independent and strong predictor
of coronary heart disease, stroke, and other forms of cardiovascular
disease. This new feature represents a significant advance in densitometry
as compared to conventional bone density scanners, which only look at
average bone density.
Hip Structure Analysis or HSA(TM) for short, is designed to assist
physicians in determining if a patient's bones have been weakened so as to
require treatment and, if the patient is being treated, whether the
patient's bones are getting stronger. HSA, the leading hip structure
analysis method for DXA scans in research and pharmaceutical studies, uses
specialized software to examine the structural geometry of two-dimensional
DXA scan images.
New Extremity MRI Product Tailored for the Orthopedic
MarketHighlighting Hologic's expanding effort in serving the orthopedic and
rheumatology imaging market, Hologic will feature a new product --
Opera(TM) extremity MRI for orthopedic specialists. Opera E-MRI opens a
wider array of diagnostic possibilities with complete imaging of all
extremities, including hip and shoulder applications. Real time positioning
speeds set up and significantly reduces exam time. The comfortable, open
design of Opera reduces anxiety and enhances patient comfort.
Bringing the Finest Detail to Extremity Imaging
Extremity surgery demands visualization of the finest detail with the
lowest x-ray dose. Hologic RSNA'06 will demonstrate the Fluoroscan
InSight(TM) mini C-arm -- a system specifically designed to deliver high
resolution, low dose images with a surgeon-friendly user interface and
unlimited flexibility.
Hologic Works in Progress* featured at RSNA'06
Breast Tomosynthesis with a Selenium Based Detector Investigational
DeviceBuilding on the findings of more than three years of diagnostic and
screening clinical trials at six clinical sites, visitors will have the
chance to self evaluate their skills in reading two dimension and three
dimension images of the same patient and see if they can find a difference
in cancer detection rates. A specially designed booth will allow visitors
to see a demonstration of how two-dimensional and three-dimensional
imaging, breast tomosynthesis, can be accomplished on a system much like
the Hologic Selenia digital mammography system.
SecurView and Citra Software
Citra is expected to bring physicians a universal and 'CAD-intelligent'
system for reviewing digital mammography images and, if needed, comparing
them with digitized prior film images on the popular SecurView workstation.
Citra optimizes R2 CAD mark and R2 CAD information display to assist the
radiologist in review and decision-making, while streamlining workflow.
Citra and SecurView will allow the physician to compare current images with
images from prior years by equalizing the size of all displayed images even
when the images come from different size detectors or film.
3-D Imaging on Discovery Bone Densitometers
Clinicians have long realized the importance of 3-D femur analysis to
the measurement of bone strength. But clinical and research applications
with CT so far have been limited by the high radiation dose necessary and
the difficulty in accurate and reproducible segmentation of bone from soft
tissue. At RSNA'06 we'll update you on our collaboration with The Johns
Hopkins University Center for Computer-Integrated Surgical Systems and
Technology on 3-D modeling of the hip using the Hologic Discovery bone
densitometer.
* Caution. Investigational device. Limited by Federal law to
investigational use.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of
premium diagnostic and medical imaging systems dedicated to serving the
healthcare needs of women, and a leading developer of innovative imaging
technology for digital radiography and breast imaging. Hologic's core
business units are focused on mammography and breast biopsy, osteoporosis
assessment, and mini C- arm and extremity MRI imaging for orthopedic
applications. For more information visit http://www.hologic.com.
Forward Looking Disclaimer
This News Release contains forward-looking information that involves
risks and uncertainties, including statements about Hologic's plans,
objectives, expectations and intentions. Such statements include, without
limitation, statements regarding the expected performance and benefits of
its products and products under development. These forward-looking
statements are subject to known and unknown risks and uncertainties that
could cause actual results to differ materially from those anticipated.
Factors that could cause actual results to materially differ include,
without limitation: risks inherent in the development of new products and
the enhancement of existing products, including technical and regulatory
risks, such as the ability to obtain FDA approval or clearances to market
products developed, cost overruns and delays; the risk that newly
introduced products may contain undetected errors or defects or otherwise
not perform as anticipated; Hologic's ability to predict accurately the
demand for its products and to develop strategies to address its markets
successfully; technical innovations that could render products marketed or
under development by Hologic obsolete; competition; and reimbursement
policies for the use of Hologic's products. Other factors that could
adversely affect Hologic's business and prospects are described in
Hologic's filings with the Securities and Exchange Commission. Hologic
expressly disclaims any obligation or undertaking to release publicly any
updates or revisions to any such statements to reflect any change in
Hologic's expectations or any change in events, conditions or circumstances
on which any such statement is based.
Contact:
Glenn P. Muir Frances Crecco
Executive Vice President & CFO Director, Investor Relations
Hologic, Inc. Hologic, Inc.
(781) 999-7300 (781) 999-7377
SOURCE Hologic, Inc.
 back to top
Related links:
http://www.hologic.com/
CONTACT:
Glenn P. Muir, Executive Vice President &
CFO, +1-781-999-7300, or Frances Crecco, Director, Investor
Relations, +1-781-999-7377, both of Hologic, Inc.
|
